Clinton Yam
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics
Most-Cited Works
- → Monotherapy with a Tumor-Targeting Mutant of S. typhimurium Inhibits Liver Metastasis in a Mouse Model of Pancreatic Cancer(2009)133 cited
- → Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field(2017)104 cited
- → Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer(2021)74 cited
- → MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer(2022)69 cited
- → Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma(2021)69 cited
- → Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer(2018)59 cited
- Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer.(2020)
- → Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study(2019)42 cited
- → Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer(2021)42 cited
- → Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI(2023)41 cited